This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Do you own shares of Rochester Medical Corporation (NASDAQ GM: ROCM)?
Did you purchase any of your shares prior to September 4, 2013?
Do you think the proposed buyout price is too low?
Do you want to discuss your rights?
Rigrodsky & Long, P.A. announces that it is investigating potential legal claims against the board of directors of Rochester Medical Corporation (“ROCM” or the “Company”) (NASDAQ GM:
ROCM) regarding possible breaches of fiduciary duties and other violations of law related to the Company’s entry into an agreement to be acquired by C.R. Bard, Inc. (“Bard”) (NYSE:
BCR) in a transaction valued at approximately $262 million.